STANÍK, Michal, Alexandr POPRACH, D. MACIK, I. CAPAK, Denisa KREJČÍ, N. MARECKOVA, Radek LAKOMÝ, Jiří JARKOVSKÝ and Jan DOLEŽEL. Clinically node-positive bladder cancer: oncological results of induction chemotherapy and consolidative surgery. Neoplasma. Bratislava: Slovenská akademie vied, 2018, vol. 65, No 2, p. 287-291. ISSN 0028-2685. Available from: https://dx.doi.org/10.4149/neo_2018_170403N239.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Clinically node-positive bladder cancer: oncological results of induction chemotherapy and consolidative surgery
Authors STANÍK, Michal (703 Slovakia, guarantor), Alexandr POPRACH (203 Czech Republic), D. MACIK (203 Czech Republic), I. CAPAK (203 Czech Republic), Denisa KREJČÍ (203 Czech Republic, belonging to the institution), N. MARECKOVA (203 Czech Republic), Radek LAKOMÝ (203 Czech Republic), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution) and Jan DOLEŽEL (203 Czech Republic).
Edition Neoplasma, Bratislava, Slovenská akademie vied, 2018, 0028-2685.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher Slovakia
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.771
RIV identification code RIV/00216224:14110/18:00104048
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.4149/neo_2018_170403N239
UT WoS 000435149800016
Keywords in English urinary bladder neoplasms; lymphadenopathy; combined modality therapy; induction chemotherapy; cystectomy
Tags 14119612, rivok
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 9/2/2019 21:39.
Abstract
Patients with clinically node-positive bladder cancer have a poor prognosis, with many receiving only palliative chemotherapy. We evaluated oncological results in bladder cancer patients with clinically regional and supraregional lymphadenopathy treated with induction chemotherapy (IC) and consolidative cystectomy. Twenty-five patients with clinically node-positive bladder cancer (including pelvic and retroperitoneal nodes) were treated with 2-4 cycles of IC followed by consolidative cystectomy between 2010 and 2016. Pathologic complete response (pCR) was defined as no residual tumor in the final specimen (ypT0N0). The 3-year cancer-specific (CSS) and recurrence-free survival (RFS) for the whole cohort were 52% and 39%, respectively. The 3-year RFS differed according to volume of nodal metastases, the rates were 56% for minimal nodal disease (cN1) versus 33% for cN2-3 and 0% for cM1 disease (p<0.001). pCR was seen in 7 (28%) patients; 50% in cN1 versus 13% in cN3-M1. pCR associated with 3-year CSS of 80% versus 45% in patients with persistent disease aft er IC. In conclusion, a multimodal approach to patients with clinically node-positive bladder cancer, consisting of IC followed by consolidative surgery, may achieve long-term survival in selected patients. Better results may be expected in patients with initially minimal nodal burden and complete pathologic response to chemotherapy. Further studies are warranted to improve patient selection for consolidative surgery, especially with supra-regional metastases.
PrintDisplayed: 26/7/2024 16:30